Roivant Sciences Ltd. share price logo

Roivant Sciences Ltd. Share Price

NASDAQ: ROIV

Mid Cap

$15.27

+1.09

(+7.69%)

as on

Roivant Sciences Ltd. Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $15.22
    $16.05
    downward going graph

    0.33%

    Downside

    5.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.73
    $14.48
    downward going graph

    42.83%

    Downside

    -5.21%

    Upside

    downward going graph

Roivant Sciences Ltd. share price movements today

Previous Close
$14.18
Open
$15.77
Volume
29.0M
Day's Low - High
$15.22 - $16.05
52 Week Low - High
$8.73 - $14.48

Roivant Sciences Ltd. Historical Returns

1 Month Return
+ 19.66 %
3 Month Return
+ 27.63 %
1 Year Return
+ 17.68 %
3 Year Return
+ 336.31 %
5 Year Return
0 %

Roivant Sciences Ltd. Stock Fundamentals & Key Indicators

Check Roivant Sciences Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5B

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.96%

PE Ratio (TTM)

1.88

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

0

EBITDA

-1.1B

Revenue (TTM)

23.2M

Profit Margin

0.00%

Return On Equity TTM

85578200.00%

Roivant Sciences Ltd. Stock Valuation

Track how Roivant Sciences Ltd. P/E has moved over time to understand its valuation trends.

Roivant Sciences Ltd. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 17, 2025

Today (1.88x)

September 17, 2025

Industry (10.13x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 1.88x

Roivant Sciences Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Roivant Sciences Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$9.5BNA1.880.00%
BUY$60.5B252.04%-505.15-12.96%
NA$39.0BNANA-3.89%
BUY$100.3B44.17%27.8531.86%
BUY$59.6B1.78%14.131.37%

Stock Returns calculator for Roivant Sciences Ltd. Stock including INR - Dollar returns

The Roivant Sciences Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Roivant Sciences Ltd. investment value today

Current value as on today

₹1,31,320

Returns

₹31,320

(+31.32%)

Returns from Roivant Sciences Ltd. Stock

₹26,722 (+26.72%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Roivant Sciences Ltd. Stock

Based on 17 analysts

BUY

88.24%

Buy

11.76%

Hold

0.00%

Sell

Based on 17 analysts, 88.24% of analysts recommend a 'BUY' rating for Roivant Sciences Ltd.. Average target price of $17.1

Roivant Sciences Ltd. Share Price Target

Get share price movements and forecasts by analysts on Roivant Sciences Ltd..

What analysts predicted

10.7%UPSIDE

Target Price

$17.1

Current Price

$15.27

Analyzed by

17 Analysts

Target

$17.10

Roivant Sciences Ltd. target price $17.1, a slight upside of 10.7% compared to current price of $15.27. According to 17 analysts rating.

Roivant Sciences Ltd. Stock's Interest Amongst Investors

Search interest for Roivant Sciences Ltd. Stock has increased by 15% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:15% versus previous 30 day period

Roivant Sciences Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
27
21
37
37
28
55
4
9
7
2
Gross Profit
17
17
33
33
24
51
4
8
5
2
Operating Income
-234
-276
276
5,060
-266
-120
-341
-274
-284
-284
EBITDA
-163
-309
-311
-310
5,113
88
-224
-271
-201
-283
Interest Expense
8
8
9
9
7
13
13
-
-
-
Depreciation
5
5
5
5
5
4
4
2
1
1
Income Before Tax
-179
-326
-327
5,098
-191
70
-224
-234
-203
-269
Income Tax Expense
-3
1
3
25
-8
12
12
-25
49
4
Net Income
-33
-291
-304
5,096
-151
95
-230
169
-206
-223
Net Profit Margin
-122.80%
-1349.50%
-820.27%
13721.55%
-522.35%
172.85%
-5143.78%
1878.25%
-2727.54%
-10292.86%

Roivant Sciences Ltd. Annual Profit & Loss

All numbers in Millions USD

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
2
67
23
55
61
124
29
Gross Profit
1
66
21
46
48
96
28
Operating Income
-748
-532
-1,070
-1,351
-1,175
4,242
-1,003
EBITDA
138
-553
-895
-916
-1,178
4,310
-674
Interest Expense
7
7
2
7
27
34
-
Depreciation
-
-
-
5
18
22
14
Income Before Tax
-807
-560
-898
-923
-1,224
4,253
-681
Income Tax Expense
2
7
1
0
5
22
48
Net Income
-1,041
1,200
-809
-845
-1,009
4,348
-171
Net Profit Margin
-44835.15%
1773.57%
-3400.86%
-1528.89%
-1646.59%
3484.86%
-591.96%

Roivant Sciences Ltd. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-327
-331
5,072
-182
57
-187
-157
-252
-273
Operating Cash Flow
-249
-196
-210
-108
-192
-266
-207
-172
-204
Investing Cash Flow
0
-36
5,233
6
0
-3,293
454
1,074
-1,085
Financing Cash Flow
7
207
236
-32
-660
-109
-272
-177
-187
Change in Cash
-242
-26
5,262
-135
-857
-3,664
32
723
-1,477

Roivant Sciences Ltd. Annual Cash Flow

All numbers in Millions USD

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
-519
-900
-924
-1,115
4,231
-356
Operating Cash Flow
-761
-552
-677
-843
-765
-839
Investing Cash Flow
1,694
-31
303
-44
5,203
-1,766
Financing Cash Flow
217
456
306
499
419
-1,219
Change in Cash
1,335
-127
-67
-381
4,858
-3,824

Global Institutional Holdings in Roivant Sciences Ltd.

Funds
Holdings
Qvt Financial LP
9.64%
SB INVESTMENT ADVISERS (UK) LTD
9.06%
FMR Inc
7.57%
Viking Global Investors LP
6.74%
BlackRock Inc
6.1%

Roivant Sciences Ltd. News & Key Events

  • img

    Today's Timeline - 17 September

    Wed, 09:30 PM

    -

    Roivant Sciences stock rises 11% after positive Phase 3 trial results for brepocitinib in treating dermatomyositis.

Insights on Roivant Sciences Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ROIV stock has moved up by 20.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ROIV has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 50.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 169.38M → -223.35M (in $), with an average decrease of 115.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 9.01M → 2.17M (in $), with an average decrease of 43.7% per quarter

About Roivant Sciences Ltd.

roivant is a global healthcare company focused on rapidly developing innovative medicines. we believe that the key to unlocking innovation in drug discovery and drug commercialization is to reduce the time and cost of the drug development process. we solve this problem by building vants – nimble, entrepreneurial biotech companies with a unique approach to sourcing talent, aligning economic incentives, and deploying technology to drive greater efficiency in pharma r&d; and commercialization. the goal of our model is to ensure that important medicines rapidly reach patients who suffer from serious diseases. we focus on disease areas where the magnitude of r&d; investment from industry is disproportionately low relative to societal medical needs. we also launch new vants to directly improve the process of developing and commercializing new medicines. our pipeline spans multiple therapeutic areas through partnerships with academic institutions and biopharmaceutical companies, including tak
OrganisationRoivant Sciences Ltd.
Headquarters11-12 St. James's Square, London, United Kingdom, SW1Y 4LB
IndustryFinancial
CEOMr. Matthew Gline
E-voting on sharesClick here to vote

Key Management of Roivant Sciences Ltd.

Name

Title

Mr. Matthew Gline

CEO & Director

Dr. Huafeng Xu Ph.D.

Chief Technology Officer

Mr. Drew Kramer

Chief Information Officer

Ms. Kelly Graff

Head of People

Dr. Eric Venker M.D., Pharm.D.

President & CEO of Immunovant

Dr. Mayukh Sukhatme M.D.

President, Chief Investment Officer & Director

Mr. Richard Pulik

Chief Financial Officer

Ms. Jennifer Humes

Chief Accounting Officer

Dr. Frank M. Torti M.B.A., M.D.

President & Vant Chair

Mr. Josh Chen J.D.

General Counsel

FAQs

What is Roivant Sciences Ltd. share price today?

Roivant Sciences Ltd. share price today is $15.27 as on at the close of the market. Roivant Sciences Ltd. share today touched a day high of $16.05 and a low of $15.22.

What is the 52 week high and 52 week low for Roivant Sciences Ltd. share?

Roivant Sciences Ltd. share touched a 52 week high of $14.48 on and a 52 week low of $8.73 on . Roivant Sciences Ltd. stock price today i.e. is closed at $15.27,which is -5.49% down from its 52 week high and 74.91% up from its 52 week low.

What is Roivant Sciences Ltd.'s market capitalisation today?

Roivant Sciences Ltd. market capitalisation is $0.01T as on .

How to invest in Roivant Sciences Ltd. Stock (ROIV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Roivant Sciences Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Roivant Sciences Ltd. Shares that will get you 0.0982 shares as per Roivant Sciences Ltd. share price of $15.27 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Roivant Sciences Ltd. Stock (ROIV) from India?

Indian investors can start investing in Roivant Sciences Ltd. (ROIV) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Roivant Sciences Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Roivant Sciences Ltd. share’s latest price of $15.27 as on September 18, 2025 at 1:29 am IST, you will get 0.6549 shares of Roivant Sciences Ltd.. Learn more about fractional shares .